Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19683533 | 0.94 | MAOB (0.46) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL26255497 | 0.92 | MAOB (0.62) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL19683364 | 0.92 | MAOB (0.47) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL31672328 | 0.92 | MAOB (0.47) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL24369515 | 0.91 | MAOB (0.60) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL12230534 | 0.91 | MAOB (0.60) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL14900871 | 0.91 | MAOB (0.49) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL24368895 | 0.89 | MAOB (0.49) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL18590858 | 0.89 | MAOB (0.47) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL13475658 | 0.89 | MAOB (0.66) | MAOBCA1CA2CA9ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304595-A1 | Electroactive Compounds | LG CHEM, LTD. (KR) | 2025-10-02 | — | — | US | disclosed |
| US-11239426-B2 | Electroactive compounds | LG CHEM, LTD. | 2022-02-01 | — | — | US | disclosed |
| WO-2018097937-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-31 | — | — | WO | disclosed |
| WO-2017210072-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304595-A1 | Electroactive Compounds | NAT1, NES, SULT1E1 | MAOB 2288/4885CA1 2042/4885CA2 2857/4885 |
| US-11239426-B2 | Electroactive compounds | KCNN2, HCN2, KCNN3 | MAOB 122/4885CA1 629/4885CA2 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.